Supplements: Fadogia Agrestis

Fadogia agrestis is a case study in how social media can create a supplement market from zero — bypassing the evidence accumulation process entirely.

How This Happened

Before 2022, Fadogia agrestis was essentially unknown in Western sports nutrition. It is a West African shrub (Rubiaceae family) used in traditional Nigerian medicine. A handful of Nigerian researchers, primarily Yakubu and colleagues at the University of Ilorin, had published rodent studies on its aphrodisiac and testosterone-related effects in the mid-2000s.

When the herb was mentioned on a major science-adjacent podcast in 2022–2023 as part of a testosterone optimization discussion, consumer search volume spiked overnight. Supplement companies had products on shelves within months. Millions of consumers began purchasing a product with no human clinical data.

The Entire Evidence Base

Claim	Evidence Source	Species	Human Evidence	Safety Data	Verdict
Increases testosterone	Yakubu 2005 (PMID 16281095)	Male Wistar rats	Zero	Rodent only	Unproven in humans
Increases LH	Rodent studies	Rats	Zero	Rodent only	Mechanism unconfirmed in humans
Improves sexual behavior	Yakubu 2005, Ang 2004	Rats	Zero	Rodent only	Not applicable to humans
Safe at supplement doses	No studies	N/A	Zero	Unknown	Cannot be established
Testicular toxicity risk	Yakubu 2007 (PMID 17499482)	Male Wistar rats	Not studied	Documented in rodents	Concerning; human relevance unknown
Heavy metal contamination	Market product analyses	N/A	Relevant	Documented in products	Real safety concern

Why Rodent Data Cannot Substitute for Human Data

Rodent models are valuable for generating hypotheses and studying mechanisms. They are not adequate grounds for human supplementation when:

1. The bioactive compounds are not fully characterized
2. No human pharmacokinetic data exists (absorption, half-life, dose-response)
3. Toxicity signals have been observed in the same rodent model
4. The proposed mechanism (LH stimulation) has not been confirmed in human cells or tissue

The rodent testosterone effects from aqueous extract may be real in rodents. The therapeutic index in that same rodent model is narrow — histological testicular changes were observed at doses not dramatically higher than the testosterone-increasing doses (Yakubu 2007, PMID 17499482). This pattern would trigger safety alarm bells in any pharmaceutical development program.

The Contamination Problem

Fadogia agrestis is sourced primarily from Nigeria and other West African countries with limited agricultural regulation and quality control infrastructure. The same contamination issues documented in tongkat ali — lead, cadmium, mercury — apply here, potentially at higher severity given the less-developed supplement supply chain. A certificate of analysis from an ISO 17025-accredited laboratory is essential for any West African botanical product.

The Honest Position

Fadogia agrestis is an interesting traditional herb that deserves rigorous human clinical investigation. That investigation has not been done. Until human RCTs with safety monitoring are published, supplementing with an uncharacterized compound that has shown potential testicular toxicity in rodents and zero human safety data is not evidence-based practice.

The popularity of fadogia agrestis illustrates how supplement demand can be created by authority figures without peer-reviewed evidence — and how quickly the industry supplies that demand, without waiting for the evidence that should precede it.